Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
Dupixent (dupilumab) - Sanofi, Regeneron
Recurrent Podagra Following Dupilumab and Tezepelumab Therapy for Chronic Rhinosinusitis with Nasal Polyps (ACAAI 2026) - Oct 28, 2026 - Abstract #M113; Pres time: Nov 14, 2026; 12:10 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 2; No abstract available 
Chronic Rhinosinusitis With Nasal Polyps • Immunology • Nasal Polyps • Otorhinolaryngology • Respiratory Diseases • Sinusitis
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next